CHE
Chemed CorporationNYSEHealthcare$380.60+0.80%ClosedMarket Cap: $5.37B
As of 2026-04-06
Valuation
P/E (TTM)
20.25
PEG
—
P/B
5.44
P/S
2.12
EV/EBITDA
12.86
DCF Value
$740.84
FCF Yield
6.1%
Div Yield
0.6%
Margins & Returns
Gross Margin
31.1%
Operating Margin
13.4%
Net Margin
10.5%
ROE
23.9%
ROA
29.8%
ROIC
18.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $639.3M | 32.2% | $100.7M | $76.8M | $5.48 | $0.60 |
| FY 2025 | $2.53B | 30.0% | $338.2M | $265.2M | $18.42 | $2.20 |
| Q3 2025 | $624.9M | 28.9% | $74.8M | $64.2M | $4.46 | $0.60 |
| Q2 2025 | $618.8M | 29.8% | $68.1M | $52.5M | $3.57 | $0.50 |
| Q1 2025 | $646.9M | 33.5% | $94.8M | $71.8M | $4.86 | $0.50 |
| Q4 2024 | $640.0M | 36.6% | $113.9M | $90.3M | $6.02 | $0.50 |
| FY 2024 | $2.43B | 35.1% | $366.5M | $302.0M | $19.89 | $1.80 |
| Q3 2024 | $606.2M | 34.6% | $92.2M | $75.8M | $5.02 | $0.50 |
| Q2 2024 | $595.9M | 34.6% | $88.1M | $70.9M | $4.65 | $0.40 |
| Q1 2024 | $589.2M | 34.6% | $72.3M | $65.0M | $4.24 | $0.40 |
| Q4 2023 | $585.9M | 38.8% | $111.4M | $90.1M | $5.90 | $0.40 |
| FY 2023 | $2.26B | 35.3% | $340.6M | $272.5M | $17.93 | $1.56 |